TXG — 10x Genomics, Inc.
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2019-09-12.
Performance
Technicals
Others in Healthcare
Measured signals that fired on TXG
| date | signal | measured base rate |
|---|---|---|
| 2026-08-10 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-08-07 | Breakout to a 52-week high price | -1.00% over 21 days · t = -8.58 · n = 24,386 statistically distinguishable from its control group |
| 2026-07-10 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-06-22 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-05-29 | Fair value gap, bullish structure | -0.67% over 21 days · t = -6.43 · n = 111,973 statistically distinguishable from its control group |
| 2026-05-22 | Bollinger bandwidth breaks out of its own compression structure | -0.63% over 21 days · t = -2.80 · n = 7,196 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-14 | Teichmann Sarah A. Director | Open-market sale 10b5-1 plan | 2.3K | 57.15 | 129.9K |
| 2026-08-13 | Teichmann Sarah A. Director | Open-market sale 10b5-1 plan | 5.3K | 57.29 | 302.4K |
| 2026-08-11 | STUELPNAGEL JOHN R Director | Open-market sale | 17.0K | 57.58 | 978.9K |
| 2026-08-11 | STUELPNAGEL JOHN R Director | Open-market sale | 3.0K | 58.73 | 176.2K |
| 2026-06-22 | Saxonov Serge Chief Executive Officer | Open-market sale 10b5-1 plan | 9.8K | 35.32 | 346.8K |
| 2026-06-22 | Saxonov Serge Chief Executive Officer | Open-market sale 10b5-1 plan | 10.0K | 34.28 | 342.5K |
| 2026-06-22 | Saxonov Serge Chief Executive Officer | Open-market sale 10b5-1 plan | 8.5K | 33.29 | 283.9K |
| 2026-06-22 | Saxonov Serge Chief Executive Officer | Open-market sale 10b5-1 plan | 1.7K | 36.16 | 60.1K |
| 2026-06-16 | SULIMAN SHEHNAAZ Director | Open-market sale 10b5-1 plan | 5.4K | 32.59 | 174.6K |
| 2026-06-16 | SULIMAN SHEHNAAZ Director | Open-market sale 10b5-1 plan | 364 | 33.27 | 12.1K |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| FMR LLC | 376.6M | 17.7M |
| ARK Investment Management LLC | 248.8M | 11.7M |
| BlackRock, Inc. | 214.0M | 10.1M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 146.8M | 6.9M |
| Quantinno Capital Management LP | 114.9M | 5.4M |
| VANGUARD CAPITAL MANAGEMENT LLC | 111.9M | 5.3M |
| Sumitomo Mitsui Trust Group, Inc. | 108.5M | 5.1M |
| Amova Asset Management Americas, Inc. | 108.3M | 5.1M |
| GOLDMAN SACHS GROUP INC | 84.3M | 4.0M |
| GEODE CAPITAL MANAGEMENT, LLC | 61.7M | 2.9M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- 10x Genomics (TXG) Q2 2026 Earnings Call Transcript · 2026-08-14
Ask the AI about TXG
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →